Free Trial

Organigram Global (OGI) to Release Earnings on Wednesday

Organigram Global logo with Medical background

Key Points

  • Organigram Global is set to release its Q3 2025 earnings on August 13th, with analysts predicting a loss of ($0.01) per share and expected revenue of $68.04 million.
  • The company's stock opened at $1.38 and has a market cap of $184.96 million, with a fifty-two week trading range between $0.85 and $2.08.
  • Organigram Global produces and sells cannabis products in Canada, including medical and recreational cannabis under various brand names.
  • Looking to Export and Analyze Organigram Global Data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Organigram Global (NASDAQ:OGI - Get Free Report) is anticipated to release its Q3 2025 earnings data before the market opens on Wednesday, August 13th. Analysts expect the company to announce earnings of ($0.01) per share and revenue of $68.04 million for the quarter.

Organigram Global Trading Up 2.5%

OGI stock traded up $0.04 on Friday, hitting $1.45. The company's stock had a trading volume of 601,158 shares, compared to its average volume of 682,039. The firm has a 50 day moving average of $1.40 and a two-hundred day moving average of $1.27. Organigram Global has a 1 year low of $0.85 and a 1 year high of $2.08. The stock has a market cap of $193.67 million, a price-to-earnings ratio of 14.45 and a beta of 1.45.

Organigram Global Company Profile

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

Read More

Earnings History for Organigram Global (NASDAQ:OGI)

Should You Invest $1,000 in Organigram Global Right Now?

Before you consider Organigram Global, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram Global wasn't on the list.

While Organigram Global currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines